BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2777410)

  • 21. Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid.
    Coakham HB; Garson JA; Brownell B; Allan PM; Harper EI; Lane EB; Kemshead JT
    Lancet; 1984 May; 1(8386):1095-8. PubMed ID: 6202990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer.
    Ino R; Sada KE; Miyauchi A; Hashimoto D; Nojima S; Yamanaka S; Kawamura M
    Acta Med Okayama; 2021; 75(5):659-661. PubMed ID: 34703051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
    Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric cancer with isolated leptomeningeal metastases: a case report.
    Sambasivaiah K; Reddy K; Lakshmi AY; Menon B; Varma VS
    Trop Gastroenterol; 2007; 28(1):39-40. PubMed ID: 17896611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.
    Chamberlain MC
    Neurology; 1998 Apr; 50(4):1173-5. PubMed ID: 9566421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
    Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
    Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptomeningeal carcinomatosis presenting as eosinophilic meningitis.
    Conrad KA; Gross JL; Trojanowski JQ
    Acta Cytol; 1986; 30(1):29-31. PubMed ID: 3456181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinomatous meningitis in solid tumours.
    Jayson GC; Howell A
    Ann Oncol; 1996 Oct; 7(8):773-86. PubMed ID: 8922190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
    Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
    J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
    Jacobi C; Reiber H; Felgenhauer K
    J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
    Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
    Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid abnormalities in meningeosis neoplastica: a retrospective 12-year analysis.
    Djukic M; Trimmel R; Nagel I; Spreer A; Lange P; Stadelmann C; Nau R
    Fluids Barriers CNS; 2017 Mar; 14(1):7. PubMed ID: 28351400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of immunocytochemistry in diagnosis of meningeal carcinomatosis in a patient with unknown primary site.
    Lee CT; Fan FS; Chen PM; Liu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Nov; 50(5):429-33. PubMed ID: 1284045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LDH isoenzymes in cerebrospinal fluid in various brain tumours.
    Lampl Y; Paniri Y; Eshel Y; Sarova-Pinhas I
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):697-9. PubMed ID: 2213048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocytochemical localization of carcinoembryonic antigen in cerebrospinal fluid with metastatic carcinoma of the stomach: report of four cases.
    Iwa N; Yutani C; Kobayashi TK
    Diagn Cytopathol; 1988; 4(4):312-5. PubMed ID: 2474422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry.
    Jorda M; Ganjei-Azar P; Nadji M
    Arch Neurol; 1998 Feb; 55(2):181-4. PubMed ID: 9482359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
    Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
    Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Brain metastasis and the carcinoembryonic antigen].
    Noris-García E; Escobar-Pérez X
    Rev Neurol; 2004 Feb 1-15; 38(3):267-70. PubMed ID: 14963857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients.
    Ogawa Y; Saraya T; Noda A; Kurokawa N; Sakuma S; Aso K; Mikura S; Oda M; Ishida M; Honda K; Nakamoto K; Tamura M; Takata S; Ishii H; Takizawa H
    Medicine (Baltimore); 2021 Apr; 100(14):e25367. PubMed ID: 33832119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.